FREMONT, CA--(Marketwire - June 17, 2008) - Cardima, Inc. (OTCBB: CADM), a medical device company focused on the treatment of Atrial Fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, has seen its products highlighted in clinical work, key meetings and studies. The technology has been scientifically proven to be capable of creating continuous, linear, transmural lesions during beating heart surgery through an entirely thorocoscopic approach.
